Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 14

1.

Antidiabetic potentials of Momordica charantia: multiple mechanisms behind the effects.

Chaturvedi P.

J Med Food. 2012 Feb;15(2):101-7. doi: 10.1089/jmf.2010.0258. Epub 2011 Dec 22. Review.

PMID:
22191631
[PubMed - indexed for MEDLINE]
2.

Anti-diabetic and hypoglycaemic effects of Momordica charantia (bitter melon): a mini review.

Leung L, Birtwhistle R, Kotecha J, Hannah S, Cuthbertson S.

Br J Nutr. 2009 Dec;102(12):1703-8. doi: 10.1017/S0007114509992054. Epub . Review.

PMID:
19825210
[PubMed - indexed for MEDLINE]
3.

Bitter gourd (Momordica Charantia): A dietary approach to hyperglycemia.

Krawinkel MB, Keding GB.

Nutr Rev. 2006 Jul;64(7 Pt 1):331-7. Review.

PMID:
16910221
[PubMed - indexed for MEDLINE]
4.

Traditional chinese medicine in treatment of metabolic syndrome.

Yin J, Zhang H, Ye J.

Endocr Metab Immune Disord Drug Targets. 2008 Jun;8(2):99-111. Review.

PMID:
18537696
[PubMed - indexed for MEDLINE]
Free PMC Article
5.

Bitter gourd (Momordica charantia) is a cornucopia of health: a review of its credited antidiabetic, anti-HIV, and antitumor properties.

Fang EF, Ng TB.

Curr Mol Med. 2011 Jul;11(5):417-36. Review.

PMID:
21568930
[PubMed - indexed for MEDLINE]
6.

Bitter melon (Momordica charantia): a review of efficacy and safety.

Basch E, Gabardi S, Ulbricht C.

Am J Health Syst Pharm. 2003 Feb 15;60(4):356-9. Review.

PMID:
12625217
[PubMed - indexed for MEDLINE]
7.

Pharmacological actions and potential uses of Momordica charantia: a review.

Grover JK, Yadav SP.

J Ethnopharmacol. 2004 Jul;93(1):123-32. Review.

PMID:
15182917
[PubMed - indexed for MEDLINE]
8.

[Study on hypoglycemic action and active constituents of Momordica charantia L].

Lu L, Zhao Y.

Zhong Yao Cai. 2002 Jun;25(6):449-51. Review. Chinese. No abstract available.

PMID:
14968781
[PubMed - indexed for MEDLINE]
9.

[Advances in the study of Momordica charantia L].

Liu X, Li S, Feng C, Yan D.

Zhong Yao Cai. 2002 Mar;25(3):211-3. Review. Chinese. No abstract available.

PMID:
14748342
[PubMed - indexed for MEDLINE]
10.

AMP-activated protein kinase in metabolic control and insulin signaling.

Towler MC, Hardie DG.

Circ Res. 2007 Feb 16;100(3):328-41. Review.

PMID:
17307971
[PubMed - indexed for MEDLINE]
Free Article
11.

Troglitazone: review and assessment of its role in the treatment of patients with impaired glucose tolerance and diabetes mellitus.

Johnson MD, Campbell LK, Campbell RK.

Ann Pharmacother. 1998 Mar;32(3):337-48. Review.

PMID:
9533065
[PubMed - indexed for MEDLINE]
12.

Metabolic and molecular action of Trigonella foenum-graecum (fenugreek) and trace metals in experimental diabetic tissues.

Baquer NZ, Kumar P, Taha A, Kale RK, Cowsik SM, McLean P.

J Biosci. 2011 Jun;36(2):383-96. Review.

PMID:
21654091
[PubMed - indexed for MEDLINE]
Free Article
13.

[Insulin effect on metabolism in skeletal muscles and the role of muscles in regulation of glucose homeostasis].

Buczkowska EO, Jarosz-Chobot P.

Przegl Lek. 2001;58(7-8):782-7. Review. Polish.

PMID:
11769387
[PubMed - indexed for MEDLINE]
14.

A review of the efficacy and safety of banaba (Lagerstroemia speciosa L.) and corosolic acid.

Stohs SJ, Miller H, Kaats GR.

Phytother Res. 2012 Mar;26(3):317-24. doi: 10.1002/ptr.3664. Epub 2011 Nov 17. Review.

PMID:
22095937
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk